Product Information
SULFACETAMIDE-SULFUR 8-4% SUSP is a generic product labeled by Westminster Pharmaceuticals LLC, priced at $0.0710 per ML under NDC 69367024516. Its NADAC has been published 272 times since Jul 21, 2021.
Strength
80; 40 mg/mL; mg/mL
Manufacturer
Westminster Pharmaceuticals LLCNDC
69367024516
Classification
Generic
Dosage Form
SUSPENSION
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
SULFACETAMIDE SODIUM; SULFURApproval Type
Unapproved
On Market Since
6/18/2021
Pharmacological Classes
Price Statistics
The NADAC for SULFACETAMIDE-SULFUR 8-4% SUSP has been published 272 times since Jul 21, 2021, and over the history we have for it it has declined 26.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0710 per ML |
|---|---|
| All-time high | $0.1568 (May 11, 2022) |
| All-time low | $0.0612 (Apr 22, 2026) |
| 52-week high | $0.0814 |
| 52-week low | $0.0612 |
| Median price | $0.1028 |
| Average price | $0.1072 |
| Largest weekly change | +55.8% (Jan 19, 2022) |
| Weeks tracked | 272 |
| Tracking since | Jul 21, 2021 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Sodium Sulfacetamide and Sulfur market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Westminster Pharmaceuticals LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Sodium Sulfacetamide and Sulfur market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Sulfonamide Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SULFACETAMIDE-SULFUR 8-4% SUSP?
The current National Average Drug Acquisition Cost (NADAC) for SULFACETAMIDE-SULFUR 8-4% SUSP, manufactured by Westminster Pharmaceuticals LLC, is $0.0710 per ML (NDC 69367024516), effective Sep 30, 2026.
How has the price of SULFACETAMIDE-SULFUR 8-4% SUSP changed over time?
Over the history we have for it, the NADAC for SULFACETAMIDE-SULFUR 8-4% SUSP has declined 26.4%. It has been tracked across 272 weekly CMS publications since Jul 21, 2021.
What are the highest and lowest recorded NADAC prices for SULFACETAMIDE-SULFUR 8-4% SUSP?
Since Jul 21, 2021, the NADAC for SULFACETAMIDE-SULFUR 8-4% SUSP has ranged from a low of $0.0612 (Apr 22, 2026) to a high of $0.1568 (May 11, 2022), with a median of $0.1028 per ML.
Are there cheaper alternatives to SULFACETAMIDE-SULFUR 8-4% SUSP?
No other NADAC-published product currently shares the active ingredient and strength of SULFACETAMIDE-SULFUR 8-4% SUSP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures SULFACETAMIDE-SULFUR 8-4% SUSP?
SULFACETAMIDE-SULFUR 8-4% SUSP (NDC 69367024516) is labeled by Westminster Pharmaceuticals LLC, and CMS classifies it as a generic product.